Home / Mirikizumab / United States
US ATC L04AC24 · updated 2 Nov 2026
Mirikizumab shortage in United States
Is there a Mirikizumab shortage in United States?
Yes. As of 2 Nov 2026, 2 Mirikizumab products are reported short in United States, the first since 22 Dec 2025. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Omvoh, Injection, 100 mg/1 mL (NDC 0002-8011-27) discontinuation | Eli Lilly and Co. | 22 Dec 2025 | not given | Not stated |
| US | Omvoh, Injection, 100 mg/1 mL (NDC 0002-8870-27) discontinuation | Eli Lilly and Co. | 22 Dec 2025 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).